These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 11312390)

  • 1. Treatment of recalcitrant orogenital ulceration of Behçet's syndrome with infliximab.
    Robertson LP; Hickling P
    Rheumatology (Oxford); 2001 Apr; 40(4):473-4. PubMed ID: 11312390
    [No Abstract]   [Full Text] [Related]  

  • 2. Infliximab treatment for severe orogenital ulceration in Behçet's disease.
    Connolly M; Armstrong JS; Buckley DA
    Br J Dermatol; 2005 Nov; 153(5):1073-5. PubMed ID: 16225632
    [No Abstract]   [Full Text] [Related]  

  • 3. Infliximab for the treatment of resistant oral ulcers in Behçet's disease: a case report and review of the literature.
    Almoznino G; Ben-Chetrit E
    Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S99-102. PubMed ID: 17949561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of genital ulcers with infliximab in Behcet's disease.
    Haugeberg G; Velken M; Johnsen V
    Ann Rheum Dis; 2004 Jun; 63(6):744-5. PubMed ID: 15140785
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful treatment of recalcitrant genital ulcers of Behçet's disease with adalimumab after failure of infliximab and etanercept.
    Olivieri I; D' Angelo S; Padula A; Leccese P; Mennillo GA
    Clin Exp Rheumatol; 2009; 27(2 Suppl 53):S112. PubMed ID: 19796550
    [No Abstract]   [Full Text] [Related]  

  • 6. [Behçet's disease - Infliximab in the treatment of mucocutaneous manifestations].
    Lestre S; Trindade F; Martins A; Baptista J; Feio AB; Lopes MJ
    Acta Reumatol Port; 2009; 34(4):633-40. PubMed ID: 20852576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late response to anti-TNF-α therapy in refractory mucocutaneous lesions of Behçet's disease.
    Aikawa NE; Gonçalves C; Silva CA; Gonçalves C; Bonfá E; de Carvalho JF
    Rheumatol Int; 2011 Aug; 31(8):1097-9. PubMed ID: 20012049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasculitis and oral and genital ulcers: Behçet's syndrome or HIV infection?
    Olivé A; Fuente MJ; Veny A; Romeu J
    Clin Exp Rheumatol; 1999; 17(1):124. PubMed ID: 10084048
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful treatment of life-threatening intestinal ulcer in Behçet's disease with infliximab: rapid healing of Behçet's ulcer with infliximab.
    Ju JH; Kwok SK; Seo SH; Yoon CH; Kim HY; Park SH
    Clin Rheumatol; 2007 Aug; 26(8):1383-5. PubMed ID: 17039261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of intestinal Behçet's syndrome with chimeric tumour necrosis factor alpha antibody.
    Travis SP; Czajkowski M; McGovern DP; Watson RG; Bell AL
    Gut; 2001 Nov; 49(5):725-8. PubMed ID: 11600479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Worsening of osteomalacia in a patient successfully treated for neuro-Behçet's disease with infliximab.
    Madanat WY; Madanat AY
    Clin Exp Rheumatol; 2008; 26(4 Suppl 50):S128-9. PubMed ID: 19026133
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of mucocutaneous manifestations in Behçet's disease with anakinra: a pilot open-label study.
    Grayson PC; Yazici Y; Merideth M; Sen HN; Davis M; Novakovich E; Joyal E; Goldbach-Mansky R; Sibley CH
    Arthritis Res Ther; 2017 Mar; 19(1):69. PubMed ID: 28335798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remission of intestinal Behçet's disease treated with anti-tumor necrosis factor alpha monoclonal antibody (Infliximab).
    Lee JH; Kim TN; Choi ST; Jang BI; Shin KC; Lee SB; Shim YR
    Korean J Intern Med; 2007 Mar; 22(1):24-7. PubMed ID: 17427642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of infliximab and adalimumab in the treatment of a patient with severe neuro-Behçet's disease.
    Belzunegui J; López L; Paniagua I; Intxausti JJ; Maíz O
    Clin Exp Rheumatol; 2008; 26(4 Suppl 50):S133-4. PubMed ID: 19026138
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of anti-tumour necrosis factor alpha (infliximab) on sight-threatening uveitis in a patient with Behçet's disease.
    Morris DS; Gavin MP; Sturrock RD
    Adv Exp Med Biol; 2003; 528():557-9. PubMed ID: 12918763
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic Hotline. Oral allicin in the treatment of Behcet's disease through attenuating oxidative stress: A pilot study in 20 patients with mucocutaneous lesions.
    Zhong J; Xian D; Xiong X; Liu J
    Dermatol Ther; 2017 Jan; 30(1):. PubMed ID: 27723197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of anti-TNF-alpha antibody infliximab in refractory entero-Behcet's disease.
    Iwata S; Saito K; Yamaoka K; Tsujimura S; Nawata M; Suzuki K; Tanaka Y
    Rheumatology (Oxford); 2009 Aug; 48(8):1012-3. PubMed ID: 19465589
    [No Abstract]   [Full Text] [Related]  

  • 18. Switching to adalimumab is effective in a case of neuro-Behcet's disease refractory to infliximab.
    Leccese P; D'Angelo S; Angela P; Coniglio G; Olivieri I
    Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S102. PubMed ID: 20868587
    [No Abstract]   [Full Text] [Related]  

  • 19. Infliximab treatment of severe genital ulcers associated with Behçet disease.
    Kasugai C; Watanabe D; Mizutani K; Masuda Y; Zako M; Mukai T; Tamada Y; Matsumoto Y
    J Am Acad Dermatol; 2010 Jan; 62(1):162-164. PubMed ID: 20082903
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-Tumor Necrosis Factor Therapy in Intestinal Behçet's Disease.
    Park J; Cheon JH
    Gut Liver; 2018 Nov; 12(6):623-632. PubMed ID: 29788675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.